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infl ammation or oxidative stress. In the cardiovascular system, GDF-15 has been identifi ed 
as a strong marker for coronary artery disease, myocardial infarction and heart failure. 
However, there are no data concerning the role and impact of GDF-15 in the occurrence of 
organ dysfunction during cardiac surgery associated with cardiopulmonary bypass (CPB).
Thirty fi ve patients, programmed to have non-urgent coronary artery bypass 
grafting, were included in our study. Arterial samples were taken in heparinized 
tubes, after anesthesia induction (IND), just before starting CPB (pre-CPB), just 
after removing of the cross clamp (UNCLAMP), after surgery (post-SURG) and 24 h 
after arrival at the cardiovascular intensive care unit (ICU). Plasma levels of GDF-15, 
myeloperoxidases (MPO), hydroperoxides and plasma antioxidant status (PAS) were 
measured at each time-point. Neutrophil gelatinase-associated lipocalin (NGAL) an 
early marker of renal dysfunction, and other classical biological factors and clinical 
data were measured before induction and in ICU.
Plasma levels of GDF-15 increased gradually during surgery and after, reaching 
more than three time IND levels in the ICU (3067±347 ng/L vs 994±83 ng/L, p<0.01). 
MPO plasma levels increased signifi cantly just after unclamping (50±10 ng/mL vs 
1139±94 ng/mL, p<0.001) while PAS signifi cantly decreased between IND and 
UNCLAMP (p<0.05). Compared with IND levels, NGAL increased signifi cantly 
(p<0.001) in ICU. IND and ICU levels of GDF-15 and NGAL were positively 
associated (respectively p=0.026 and p=0.003).
During cardiac surgery associated with CPB, GDF-15 levels in humans are 
notably increased and associated with the increase in NGAL, an early marker of renal 
injury. The MPO increase and PAS decrease confi rm the high infl ammatory status 
of this surgical procedure. 
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In congenital heart disease (CHD), the right ventricle (RV) remains compensated 
longer than in other types of pulmonary hypertension (PH). We hypothesized that 
better matched myocardial angiogenesis contributes to delay the transition to RV 
failure in CHD. 
We induced chronic PH over a 20 weeks period in a Shunt group (n=5) by creating 
an aorto to pulmonary shunt and in an chronic thromboembolic PH model (CTEPH 
group, n=5) In the Sham group (n=5), the pigs were studied 20 weeks after a left PA 
dissection. We assessed hemodynamics using right heart catherterization and RV 
structural and functional remodeling using echocardiography and pressure-volume 
loops measurement. Myocaridal angiogenesis of the RV was studied by measuring 
capillary density (CD).
At 20 weeks, mean PA pressure was more elevated in the CTEPH and Shunt 
when compared to the Sham group. TAPSE and RVFAC values were only decreased 
in CTEPH animals. Similarly, the RV elastance was signifi cantly increased and the 
ventriculo-arterial coupling was decreased only in the CTEPH group. Although the 
cardiomyocyte diameter was similarly increased in both PH groups, the CD was only 
increased in the SHUNT group.
In PH induced by systemic to pulmonary shunt, the transition from RV compensated 
hypertrophy to RV failure is delayed compared to similar PH in a CTEPH model. 
Myocardial angiogenesis or capillary density appears to be preserved in the right 
ventricle of shunt models. 
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Objective: In order to assess the feasibility of using non-heart-beating donors in 
heart transplantation, we have measured the functional and metabolic status of hearts 
submitted to normothermic ischemia before preservation using an ex-vivo pig heart model. 
Methods: 10 pigs were separated in 2 groups: Control (n=6, brain-dead group) and 
NHBD (n=4, Non-Heart-Beating Donor group). In Control, hearts were harvested 20 
min after the brachiocephalic trunk cross-clamping and were immediately reperfused. 
In NHBD, hearts were harvested 20 min after exsanguination and asphyxia, stored in 
the CRMBM solution for 2 h and then reperfused. Cardioplegic arrest was induced 
using 1 l of CRMBM solution (4°C) and the heart was reperfused for 60 min using an 
ex-vivo perfusion system with normothermic autologous blood. During reperfusion, 
functional parameters were analyzed. CK, CK-MB, inorganic phosphate and lactate 
were determined in myocardial effl uents. At the end of the protocol, hearts were 
freeze-clamped for biochemical assays. Adenine nucleotides, phosphocreatine and 
malondialdehyde (MDA) contents were measured by HPLC. Caspase-3 expression 
was studied as an index of apoptosis. Nitric oxide (NO) pathway was evaluated by NO 
synthase (NOS) isoforms expression and total nitrate concentration (NOx). 
Results: No electromechanical activity was found in NHBD compared with 
Control. CK and CK-MB were signifi cantly higher (p<0.05) in NHBD vs Control 
(19±6 vs 12±9 ng/mL and 0.53±0.4 vs 0.15±0.07 ng/mL, respectively). ATP (μMol/g 
proteins) was lower in NHBD (6±3) vs Control (34±4) (p=0.002). MDA content, used 
as a marker of oxidative stress, was measured only in NHBD (0.070±0.04 μMol/g 
proteins). Myocardial caspase-3 was not expressed in both groups. NO pathway was 
signifi cantly impaired in NHBD compared with Control with lower eNOS expression 
(p<0.0001) and NOx content (p=0.04). 
Conclusion: We reported no functional and metabolic recovery in the non-heart beating 
donor group after normothermic ischemia and reperfusion indicating that a single immersion 
of the cardiac graft during storage does not provide an optimal protection. New strategies in 
heart preservation are necessary for recruiting non-heart-beating donors. 
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Growth Differentiation Factor 15 (GDF-15) is a cytokine that is hardly or not 
expressed in physiological conditions, but increases under situations such as hypoxia, 
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Methods and Results: We prospectively included patients in a bicentric study 
(Nice University Hospital, FR – Royal Brompton Hospital, UK). Patients with complex 
congenital heart disease (CHD) were excluded. Patients with CHD were younger 
(p<0.0001;39.49±13.4 vs 64.46±15.9) with better NYHA class (p=0.004) and lower 
BNP concentrations (p<0.0001) although there was no difference in the 6-mn walk 
distance (p=0.75). The mortality rate in congenital PAH was lower (p=0.05), despite 
being less treated with advanced therapies (p=0.0001). Right ventricular (RV) inlet 
andright atrial (RA) area were larger in patients with non-congenital PH (p=0.001; 
p<0.0001) however there was no signifi cant difference in RA/LA area ratio. RA pressure 
was signifi cantly raised in non-congenital PAH (p<0.0001). RV longitudinal function 
as assessed by TAPSE was not signifi cantly different between the 2 groups (p=0.59), 
however RV fractional area change was betterin the congenital group (38.33±11.1 
vs 32.60±10.8, p=0.0003). Pulmonary TVI was signifi cantly raised in CHD patients, 
with reduced ejection time, butin contrast, Tei indexwas higher (p 0.001). The LV 
eccentricity index was higher in non-CHD patients (p=0.01).
Conclusion: Patients with congenital PAH exhibit a different right heart geometry, 
a modifi ed right-to-left interaction and RV systolic function with better radial RV 
function compared to patients with other cause of PAH, chronic thrombo-embolic PH 
and PH associated with respiratory disease. This is possibly due to the preservation of 
RV hypertrophy from birth in CHD and to chronic adaptation to elevated RV afterload.
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Introduction: Pulmonary hypertension (PHT) is a severe condition with high 
morbidity and mortality despite recent improvement in the therapeutic management. 
Contemporary prognostic equations derived from the French and US cohort mainly 
include invasive measurements. We sought to assess the relationship between the 
echocardiographic characteristics of patients with PHT followed up in our center 
and mortality.
Methods and Results: We prospectively recruited 120 consecutive patients with PHT: 
67 patients had pulmonary arterial hypertension, 30 had pulmonary hypertension associated 
with lung disease and 23 had chronic thrombo-embolic pulmonary hypertension. Clinical 
assessment and echocardiographic data were collected as well as BNP measurements 
and 6-minute walk distance (6MWD). Patients’ mean age was 66.97±15.7 years, 68.3% 
were stage III or IV NYHA. Mean BNP was 408.19±439.9 ng/L and mean 6MWD 
was 297.62±131.3. Over a median follow-up of 11.87 months [4-15.1], 23 patients died 
(19.2%). Univariate survival analysis identifi ed the following as signifi cantly associated 
with survival: Age <79 y, female gender, NYHA class I/II, greater 6MWD, lower BNP, 
greater right ventricular (RV) fractional area change (FAC), TAPSE and RVOT TVI, 
prolonged ejection time and pulmonary acceleration time, lower Tei index, right atrial 
(RA) area, pressure and RA/LA area ratio. The strongest echocardiographic predictors 
of mortality on multivariate analysis were the indexed RA area >13, RV FAC <30%, 
TAPSE ≤16mm, Ejection time/√RR <320 ms and RVOT TVI ≤11 cm, respectively 
AUC=0.75; 0.79; 0.74; 0.71 and 0.72.
Conclusion: Echocardiographic evaluation of PHT patients provides useful 
information. Simple parameters such as ejection time, pulmonary fl ow TVI, indexed 
RA area, TAPSE and RV FAC could be incorporated in a non-invasive prognostic 
score to identify very-high risk patients.
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Mitral valve repair for infective mitral regurgitation: about 3 cases
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Endocarditis of the mitral valve is frequent and is associated with specifi c features. 
Reconstruction of the damaged mitral valve is still challenging.
We evaluate the feasibility of conservative surgery in 3 patients with mitral 
regurgitation due to infective endocarditis. 
The fi rst case was a 37-year-old woman, hospitalized for left heart failure with sepsis. 
Transthoracic and transesophageal echocardiography (TTE/TEE) showed a severe mitral 
insuffi ciency (MI) with anterior mitral leafl et (AML) perforation and an important aortic 
insuffi ciency (IA) with bicuspid aortic valve (BAV). Blood cultures identifi ed Enterococcus 
foecium. She receved ampicillin and gentamicin and referred to surgery. She underwent 
an aortic valve replacement (AVR) and mitral valve repair (MVR) by transposition of 
chordae from P2 to A2, closing the defect of the AML by a pericardial patch and placement 
of a mitral annulus. The postoperative course was complicated by a persistent 3rd degree 
atrioventricular block requiring the implantation of a dual chamber pacemaker.
The second case was a 19-year-old woman, hospitalized for exploration of arthritis 
and fever. TTE and TEE revealed a BAV, several aortic vegetations, a prolapse of 
the two aortic cusps with a dislocation of the left anterior cusp causing a severe AI 
and a mycotic aneurysm of the A ML. Blood cultures isolated Streptococcus bovis. 
She was put on vancomycin and gentamicin and underwent an AVR and MVR with 
closure of the mitral defect by a heterologous pericardial patch. She had an uneventful 
postoperative course.
The third case was a 34-year-old woman, has a repetitive ischemia of the left upper 
limb. TEE showed a large package of vegetation on the anterior and posterior mitral 
valve with MI. She underwent a surgical vegetectomy, MVR by pericardial patch and 
placing of a Sovering mitral annulus. Both blood and vegetations cultures were positive 
for Streptococcus viridans. The postoperative course was uneventful until 4 years. 
MVR for endocarditis is associated with low operative mortality and morbidity. 
It is feasible with a satisfi ed clinical outcome and maintains valve competency with 
signifi cant reductions in left atrial and left ventricular dimensions after surgery. 
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Introduction: Patients with congenital pulmonary arterial hypertension (PAH) 
have a survival advantage over those with other causes of PAH. In this study we 
aimed to compare adult patients with congenital PAH (n=187) or non congenital 
PAH, chronic thrombo-embolic pulmonary hypertension (PH) and PH associated 
with lung disease (n=143).
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analyzed gender based difference in risk factors, clinical presentation, mortality and 
onset of chronic cor pulmonale.
Results: Sixty four (42.7%) patients were males and eighty six (57.3%) were 
females. The mean of age was 53 years in females and 60 years in males (p=0.02). 
Obesity was more frequent in female patients (p=0.03). Bed rest was the most common 
risk factor for thromboembolism in women and was more frequent than in men (52.3% 
vs 39.1%) but the difference was not signifi cant. Smoking was a risk factor with high 
prevalence in males compared to females (18.8% vs 2.3%, p=0.01). Acute onset of 
pulmonary embolism symptoms was more frequent in the group of women (p=0.05). 
Chest pain and dyspnea were signifi cantly more frequent in females (p=0.04 and p=0.05, 
respectively). Hypoxia was more frequent in the group of men, but the difference was 
not signifi cant (61% vs 46%, p=0.07). There were no differences in echocardiographic 
fi ndings between the two groups. Helical computed-tomography scan was used more 
commonly in males (67.2% vs 54.7; but the difference was not signifi cant) whereas, 
ventilation-perfusion scan was used more commonly in females (47.7% vs 31.3%, 
p=0.03). Male patients have required more oxygen therapy than female patients (86% vs 
74.4%, p=0.02) and thrombolytic therapy was equally used in the two groups. There was 
no difference in the in-hospital mortality rate and in the onset of chronic cor pulmonale 
between male and female patients.
Conclusion: Women have more predisposing risk factors for pulmonary embolism 
and were more symptomatic than men, but these features don’t affect the disease 
prognosis.
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Introduction: Acute pulmonary embolism is a common illness. There are differences 
between male and female patients in predisposing factors and clinical presentations of 
acute pulmonary embolism. 
Objective: To investigate the gender disparity in the distribution of predisposing 
risk factors, clinical characteristics, in-hospital management and prognosis in patients 
with acute pulmonary embolism.
Materials and Methods: we carried out a retrospective analysis of collected 
data of 150 patients with acute pulmonary embolism between 2000 and 2010. We 
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